These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33346081)

  • 1. Impact of Cavity Shave Margins on Margin Status in Patients with Pure Ductal Carcinoma In Situ.
    Howard-McNatt M; Dupont E; Tsangaris T; Garcia-Cantu C; Chiba A; Berger AC; Levine EA; Gass JS; Ollila DW; Chagpar AB;
    J Am Coll Surg; 2021 Apr; 232(4):373-378. PubMed ID: 33346081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer.
    Chagpar AB; Killelea BK; Tsangaris TN; Butler M; Stavris K; Li F; Yao X; Bossuyt V; Harigopal M; Lannin DR; Pusztai L; Horowitz NR
    N Engl J Med; 2015 Aug; 373(6):503-10. PubMed ID: 26028131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of systematic cavity shave margins in breast-conserving surgery at a large community hospital with a low baseline re-excision rate.
    Vetter C; Ashok A; Perez M; Musaad S; Rahimi G; Gohil K; Higham A
    Breast J; 2020 Oct; 26(10):1960-1965. PubMed ID: 33078470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Lumpectomy and Cavity Shave Margin Status on Recurrence and Survival in Breast-Conserving Surgery.
    Abdelsattar JM; Afridi FG; Dai Z; Yousaf N; Seldomridge A; Battin AO; Wen S; Gray D; Marsh JW; Cowher MS; Partin JF; Hazard-Jenkins H; Lupinacci K
    Am Surg; 2023 Mar; 89(3):424-433. PubMed ID: 34196595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do All Positive Margins in Breast Cancer Patients Undergoing a Partial Mastectomy Need to Be Resected?
    Chagpar AB; Tsangaris TN; Lannin DR
    J Am Coll Surg; 2018 Jul; 227(1):13-21. PubMed ID: 29524664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.
    Merrill AL; Tang R; Plichta JK; Rai U; Coopey SB; McEvoy MP; Hughes KS; Specht MC; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Oct; 23(11):3453-3458. PubMed ID: 27207096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for residual occult disease in shave margins during partial mastectomy.
    Siegel JB; Mukherjee R; Park Y; Cluver AR; Chung C; Cole DJ; Lockett MA; Klauber-DeMore N; Abbott AM
    Breast Cancer Res Treat; 2021 Sep; 189(2):471-481. PubMed ID: 34132936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection of Cavity Shave Margins in Stage 0-III Breast Cancer Patients Undergoing Breast Conserving Surgery: A Prospective Multicenter Randomized Controlled Trial.
    Dupont E; Tsangaris T; Garcia-Cantu C; Howard-McNatt M; Chiba A; Berger AC; Levine EA; Gass JS; Gallagher K; Lum SS; Martinez RD; Willis AI; Pandya SV; Brown EA; Fenton A; Mendiola A; Murray M; Solomon NL; Senthil M; Ollila DW; Edmonson D; Lazar M; Namm JP; Li F; Butler M; McGowan NE; Herrera ME; Avitan YP; Yoder B; Walters LL; McPartland T; Chagpar AB
    Ann Surg; 2021 May; 273(5):876-881. PubMed ID: 31290763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.
    Neuschatz AC; DiPetrillo T; Steinhoff M; Safaii H; Yunes M; Landa M; Chung M; Cady B; Wazer DE
    Cancer; 2002 Apr; 94(7):1917-24. PubMed ID: 11932892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of preoperative magnetic resonance imaging and lumpectomy cavity shavings on re-excision rate in pure ductal carcinoma in situ-A single institution's experience.
    So A; De La Cruz LM; Williams AD; Bahng J; Liao G; McDonald ES; Fisher CS; Czerniecki BJ; Sataloff D; Tchou J
    J Surg Oncol; 2018 Mar; 117(4):558-566. PubMed ID: 29127721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions.
    Cao D; Lin C; Woo SH; Vang R; Tsangaris TN; Argani P
    Am J Surg Pathol; 2005 Dec; 29(12):1625-32. PubMed ID: 16327435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of specimen radiography in breast-conserving therapy of ductal carcinoma in situ.
    Lange M; Reimer T; Hartmann S; Glass Ä; Stachs A
    Breast; 2016 Apr; 26():73-9. PubMed ID: 27017245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Impact of Routine Cavity Margins Versus Standard Partial Mastectomy in Breast Cancer Patients: Results of a Randomized Controlled Trial.
    Chagpar AB; Horowitz NR; Killelea BK; Tsangaris T; Longley P; Grizzle S; Loftus M; Li F; Butler M; Stavris K; Yao X; Harigopal M; Bossuyt V; Lannin DR; Pusztai L; Davidoff AJ; Gross CP
    Ann Surg; 2017 Jan; 265(1):39-44. PubMed ID: 27192352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circumferential Shaving of the Cavity in Breast-Conserving Surgery: A Randomized Controlled Trial.
    Chen K; Zhu L; Chen L; Li Q; Li S; Qiu N; Yang Y; Su F; Song E
    Ann Surg Oncol; 2019 Dec; 26(13):4256-4263. PubMed ID: 31429019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No Ink on Ductal Carcinoma
    Fregatti P; Gipponi M; Depaoli F; Murelli F; Guenzi M; Bonzano E; Ceppi M; Friedman D
    Anticancer Res; 2019 Jan; 39(1):459-466. PubMed ID: 30591495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor margins that lead to reoperation in breast cancer: A retrospective register study of 4,489 patients.
    Lepomäki M; Karhunen-Enckell U; Tuominen J; Kronqvist P; Oksala N; Murtola T; Roine A
    J Surg Oncol; 2022 Mar; 125(4):577-588. PubMed ID: 34779520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery.
    Chagpar A; Yen T; Sahin A; Hunt KK; Whitman GJ; Ames FC; Ross MI; Meric-Bernstam F; Babiera GV; Singletary SE; Kuerer HM
    Am J Surg; 2003 Oct; 186(4):371-7. PubMed ID: 14553853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoption of SSO-ASTRO Margin Guidelines for Ductal Carcinoma in Situ: What Is the Impact on Use of Additional Surgery?
    Mamtani A; Romanoff A; Baser R; Vincent A; Morrow M; Gemignani ML
    Ann Surg Oncol; 2021 Jan; 28(1):295-302. PubMed ID: 32500343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological Predictors of Positive Resection Margins in Breast-Conserving Surgery.
    Chauhan H; Jiwa N; Nagarajan VR; Thiruchelvam P; Hogben K; Al-Mufti R; Hadjiminas D; Shousha S; Cutress R; Ashrafian H; Takats Z; Leff DR
    Ann Surg Oncol; 2024 Jun; 31(6):3939-3947. PubMed ID: 38520579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.